(19)
(11) EP 1 034 284 A1

(12)

(43) Date of publication:
13.09.2000 Bulletin 2000/37

(21) Application number: 98964437.2

(22) Date of filing: 24.11.1998
(51) International Patent Classification (IPC)7C12N 15/82, C12N 15/52, C12Q 1/68, C12N 9/00, C12N 15/62, G01N 33/50, A01H 5/00
(86) International application number:
PCT/EP9807/577
(87) International publication number:
WO 9927/119 (03.06.1999 Gazette 1999/22)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 26.11.1997 US 978830

(71) Applicants:
  • Novartis AG
    4058 Basel (CH)

    BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE CY 
  • Novartis-Erfindungen Verwaltungsgesellschaft m.b.H.
    1235 Wien (AT)

    AT 

(72) Inventors:
  • WARD, Eric, Russell
    Durham, NC 27707 (US)
  • GUYER, Charles, David
    Durham, NC 27713 (US)
  • VOLRATH, Sandra, Lynn
    Durham, NC 27707 (US)
  • GÖRLACH, Jörn
    Durham, NC 27707 (US)

(74) Representative: Becker, Konrad et al
Novartis AGCorporate Intellectual PropertyPatent- und Markenabteilung
4002 Basel
4002 Basel (CH)

   


(54) METHOD AND COMPOSITIONS USEFUL FOR THE ACTIVATION OF SILENT TRANSGENES